[1]
|
Li Y, Sawalha AH, Lu Q. Aberrant DNA methylation in skin diseases [J]. J Dermatol Sci, 2009, 54:143-149. doi: 10.1016/j.jdermsci.2009.01.009 |
[2]
|
Trowbridge RM, Pittelkow MR. Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris [J]. J Drugs Dermatol, 2014, 13:111-118. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=4f7d9956d53dbb993b01aa32ee9ad4f3 |
[3]
|
Chandra A, Ray R, Senapatic S, et al. Genetic and epigenetic basis of psoriasis pathogenesis [J]. Mol Immunol, 2015, 64:313-323. doi: 10.1016/j.molimm.2014.12.014 |
[4]
|
Park GT, Han J, Park SG, et al. DNA methylation analysis of CD4+ T cells in patients with psoriasis [J]. Arch Dermatol Res, 2014, 306:259-268. doi: 10.1007/s00403-013-1432-8 |
[5]
|
Roberson ED, Liu Y, Ryan C, et al. A subset of methylated CpG sites differentiate psoriatic from normal skin [J]. J Invest Dermatol, 2012, 132:583-592. doi: 10.1038/jid.2011.348 |
[6]
|
Chandra A, Ray A, Senapati S, et al. Genetic and epigenetic basis of psoriasis pathogenesis [J]. Mol Immunol, 2015, 64:313-323. doi: 10.1016/j.molimm.2014.12.014 |
[7]
|
Kim YI, Logan JW, Mason JB, et al. DNA hypomethylation in inflammatory arthritis: reversal with methotrexate [J]. J Lab Clin Med, 1996, 128:165-172. doi: 10.1016/S0022-2143(96)90008-6 |
[8]
|
Hou R, Yin G, An P, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes [J]. J Dermatol Sci, 2013, 72:103-109. doi: 10.1016/j.jdermsci.2013.07.002 |
[9]
|
Richardson B, Scheinbart L, Strahler J, et al. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis [J]. Arthritis Rheum, 1990, 33:1665-1673. doi: 10.1002/art.1780331109 |
[10]
|
Richardson BC, Strahler JR, Pivirotto TS, et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus [J]. Arthritis Rheum, 1992, 35:647-662. doi: 10.1002/art.1780350608 |
[11]
|
Konya C, Paz Z, Tsokos GC. The role of T cells in systemic lupus erythematosus: an update [J]. Curr Opin Rheumatol, 2014, 26:493-501. doi: 10.1097/BOR.0000000000000082 |
[12]
|
Miceli-Richard C. Epigenetics and lupus [J]. Joint Bone Spine, 2015, 82:90-93. doi: 10.1016/j.jbspin.2014.03.004 |
[13]
|
Luo Y, Li Y, Su Y, et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus [J]. Br J Dermatol, 2008, 159:827-833. doi: 10.1111/j.1365-2133.2008.08758.x |
[14]
|
Wu H, Zhao M, Yoshimura A, et al. Clinial link between epigenetics and transcription factors in the induction of autoimmunity: a comprehensive review [J]. Clin Rev Allerg Immu, 2016, 50:333-344. doi: 10.1007/s12016-016-8534-y |
[15]
|
M Relle, B Foehr, A Schwarting. Epigenetic aspects of systemic lupus erythematosus [J]. Rheumatol Ther, 2015, 2:33-46. doi: 10.1007/s40744-015-0014-y |
[16]
|
Lei W, Luo Y, Lei W, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis [J]. Scand J Rheumatol, 2009, 38:369-374. doi: 10.1080/03009740902758875 |
[17]
|
Jiang H, Xiao R, Lian X, et al. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis [J]. Clin Immunol, 2012, 143:39-44. doi: 10.1016/j.clim.2012.01.005 |
[18]
|
Ozbalkan Z, Bagilar S, Kiraz S, et al. Skewed X chromosome inactivation in blood cells of women with scleroderma [J]. Arthritis Rheum, 2005, 52:1564-1570. doi: 10.1002/art.21026 |
[19]
|
Lian X, Xiao R, Hu X, et al. DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility [J]. Arthritis Rheum, 2012, 64:2338-2345. doi: 10.1002/art.34376 |
[20]
|
Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene inscleroderma fibroblasts [J]. Arthritis Rheum, 2006, 54:2271-2279. doi: 10.1002/art.21948 |
[21]
|
Sreekumar GP, Smyth Jr JR, Ambady S, et al. Analysis of the effect of endogenous viral genes in the Smyth line chicken model for autoimmune vitiligo [J]. Am J Pathol, 2000, 156:1099-1107. doi: 10.1016/S0002-9440(10)64978-4 |
[22]
|
Groudine M, Eisenman R, Weintraub H. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation [J]. Nature, 1981, 292:311-317. doi: 10.1038/292311a0 |
[23]
|
Karadag AS, Tutal E, Ertugrul DT, et al. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine in patients with vitiligo [J]. Clin Exp Dermatol, 2012, 37:62-64. doi: 10.1111/j.1365-2230.2011.04142.x |
[24]
|
Peng W, Novak N. Recent developments in atopic dermatitis [J]. Curr Opin Allergy Clin Immunol, 2014, 14:417-422. doi: 10.1097/ACI.0000000000000094 |
[25]
|
Nakamura T, Sekigawa I, Ogasawara H, et al. Expression of DNMT-1 in patients with atopic dermatitis [J]. Arch Dermatol Res, 2006, 298:253-256. doi: 10.1007/s00403-006-0682-0 |
[26]
|
Rodríguez E, Baurecht H, Wahn AF, et al. An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylationassociated with atopic dermatitis [J]. J Invest Dermato, 2014, 134:1873-1883. doi: 10.1038/jid.2014.87 |